A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin. [electronic resource]
Producer: 20110404Description: 37-43 p. digitalISSN:- 0031-7144
- Animals
- Blotting, Western
- Carbon Tetrachloride Poisoning -- pathology
- Cell Differentiation -- drug effects
- Cell Separation
- Combined Modality Therapy
- Cytochrome P-450 CYP1A1 -- metabolism
- Enzyme-Linked Immunosorbent Assay
- Flavonoids -- therapeutic use
- Hepatocytes -- drug effects
- Hydroxyproline -- metabolism
- Lipoproteins, LDL -- metabolism
- Liver -- pathology
- Liver Cirrhosis -- chemically induced
- Liver Function Tests
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- drug effects
- Rats
- Rats, Sprague-Dawley
- Urea -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.